Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)
Centre Hospitalier Universitaire Dijon
100 participants
Jan 21, 2025
OBSERVATIONAL
Conditions
Summary
The PFA (platelet function analysis) test is prescribed for the exploration of primary hemostasis and the study of platelet-willebrand factor interaction. It is performed using citrated blood, with technical difficulties and frequent alarms that may be linked to the choice of anticoagulant (citrate). It is proposed to compare the results obtained with a conventional citrate tube and a BAPA tube, which is an anticoagulant used in clinical research and which blocks coagulation by another mechanism that would have less impact on blood platelets.
Eligibility
Inclusion Criteria3
- Person having given their non-opposition
- Person of legal age
- Person receiving a haemostasis consultation at the haemophilia and haemorrhagic diseases treatment center followed by a blood sample with a PFA test prescribed by the doctor (the test is not added for the study).
Exclusion Criteria5
- persons under legal protection (curatorship, guardianship)
- persons subject to a court protection order
- pregnant, parturient or breast-feeding women
- adult incapable or unable to give consent
- minor
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
the 3 additional tubes will be taken at the same time as the blood sample taken for the routine PFA test
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06753838